Ingevity Co. (NYSE:NGVT) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. grew its holdings in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 10.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 483,976 shares of the company's stock after acquiring an additional 44,910 shares during the period. Charles Schwab Investment Management Inc. owned about 1.34% of Ingevity worth $22,853,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. Jennison Associates LLC boosted its stake in Ingevity by 1.3% in the fourth quarter. Jennison Associates LLC now owns 19,588 shares of the company's stock valued at $925,000 after acquiring an additional 249 shares during the period. First Hawaiian Bank raised its holdings in shares of Ingevity by 2.5% during the fourth quarter. First Hawaiian Bank now owns 10,160 shares of the company's stock valued at $480,000 after buying an additional 250 shares during the last quarter. Savant Capital LLC raised its holdings in shares of Ingevity by 0.4% during the fourth quarter. Savant Capital LLC now owns 84,327 shares of the company's stock valued at $3,982,000 after buying an additional 342 shares during the last quarter. Pathstone Family Office LLC raised its holdings in shares of Ingevity by 22.1% during the third quarter. Pathstone Family Office LLC now owns 4,430 shares of the company's stock valued at $211,000 after buying an additional 803 shares during the last quarter. Finally, New York State Common Retirement Fund raised its holdings in shares of Ingevity by 0.5% during the third quarter. New York State Common Retirement Fund now owns 179,012 shares of the company's stock valued at $8,523,000 after buying an additional 825 shares during the last quarter. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Ingevity Price Performance

Ingevity stock traded down $0.36 during mid-day trading on Friday, hitting $47.74. The company's stock had a trading volume of 254,040 shares, compared to its average volume of 241,489. The company has a quick ratio of 0.98, a current ratio of 1.90 and a debt-to-equity ratio of 2.48. The stock has a market capitalization of $1.73 billion, a P/E ratio of -15.35 and a beta of 1.79. Ingevity Co. has a twelve month low of $36.66 and a twelve month high of $66.18. The stock's fifty day moving average price is $49.05 and its two-hundred day moving average price is $45.44.

Ingevity (NYSE:NGVT - Get Free Report) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.15. The firm had revenue of $340.10 million for the quarter, compared to analyst estimates of $319.15 million. Ingevity had a negative net margin of 6.84% and a positive return on equity of 18.65%. The firm's quarterly revenue was down 13.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.09 earnings per share. Research analysts forecast that Ingevity Co. will post 3.78 earnings per share for the current year.

Wall Street Analyst Weigh In

NGVT has been the topic of a number of recent analyst reports. Loop Capital lifted their price target on Ingevity from $49.00 to $56.00 and gave the company a "hold" rating in a report on Tuesday, May 7th. Jefferies Financial Group raised Ingevity from a "hold" rating to a "buy" rating and boosted their target price for the stock from $52.00 to $62.00 in a report on Monday, April 22nd. Oppenheimer boosted their target price on Ingevity from $50.00 to $58.00 and gave the stock an "outperform" rating in a report on Thursday, May 2nd. Wells Fargo & Company boosted their target price on Ingevity from $43.00 to $50.00 and gave the stock an "equal weight" rating in a report on Friday, February 23rd. Finally, BMO Capital Markets boosted their target price on Ingevity from $50.00 to $55.00 and gave the stock a "market perform" rating in a report on Wednesday, May 8th. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $55.00.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.